LIN vs LQDA · P/E 34, rev $18.07B vs rev $304.5M
Linde plc Ordinary Shares (LIN) versus Liquidia Technologies Inc (LQDA) — a side-by-side from cached financials, not a winner call.
Linde plc Ordinary Shares (LIN) is a specialty chemicals company listed on US.
Liquidia Technologies Inc (LQDA) is a biotechnology company listed on US.
Latest reported LIN revenue for 2026-06-30 was $18.07B. Net income was $3.79B. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
Latest reported LQDA revenue for 2026-06-30 was $304.5M. Net income was $127.6M. LQDA currently screens at market cap $1.04B.
LIN currently screens at market cap $223.87B and trailing P/E 34.5. LQDA currently screens at market cap $1.04B.
Not investment advice. Open the LIN and LQDA stock pages for the full models.
Not investment advice.